Anti-tuberculosis treatment strategies and drug development: challenges and priorities

VA Dartois, EJ Rubin - Nature Reviews Microbiology, 2022 - nature.com
Despite two decades of intensified research to understand and cure tuberculosis disease,
biological uncertainties remain and hamper progress. However, owing to collaborative …

The use and misuse of mathematical modeling for infectious disease policymaking: lessons for the COVID-19 pandemic

LP James, JA Salomon, CO Buckee… - Medical Decision …, 2021 - journals.sagepub.com
Mathematical modeling has played a prominent and necessary role in the current
coronavirus disease 2019 (COVID-19) pandemic, with an increasing number of models …

Urogenital tuberculosis—epidemiology, pathogenesis and clinical features

A Muneer, B Macrae, S Krishnamoorthy… - Nature Reviews …, 2019 - nature.com
Tuberculosis (TB) is the most common cause of death from infectious disease worldwide. A
substantial proportion of patients presenting with extrapulmonary TB have urogenital TB (UG …

Quantifying progression and regression across the spectrum of pulmonary tuberculosis: a data synthesis study

AS Richards, B Sossen, JC Emery… - The Lancet Global …, 2023 - thelancet.com
Background Prevalence surveys show a substantial burden of subclinical (asymptomatic but
infectious) tuberculosis, from which individuals can progress, regress, or even persist in a …

Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease

JC Emery, AS Richards, KD Dale… - … of the Royal …, 2021 - royalsocietypublishing.org
Background: it is widely assumed that individuals with Mycobacterium tuberculosis (Mtb)
infection remain at lifelong risk of tuberculosis (TB) disease. However, there is substantial …

Global, regional, and national burden of HIV-negative tuberculosis, 1990–2021: findings from the Global Burden of Disease Study 2021

SX Zhang, FY Miao, J Yang, WT Zhou, S Lv… - Infectious Diseases of …, 2024 - Springer
Background Tuberculosis (TB) is a major infectious disease with significant public health
implications. Its widespread transmission, prolonged treatment duration, notable side effects …

Quantifying the rates of late reactivation tuberculosis: a systematic review

KD Dale, M Karmakar, KJ Snow, D Menzies… - The Lancet Infectious …, 2021 - thelancet.com
The risk of tuberculosis is greatest soon after infection, but Mycobacterium tuberculosis can
remain in the body latently, and individuals can develop disease in the future, sometimes …

Potential impact of tuberculosis vaccines in China, South Africa, and India

RC Harris, T Sumner, GM Knight, H Zhang… - Science translational …, 2020 - science.org
More effective tuberculosis vaccines are needed to help reach World Health Organization
tuberculosis elimination goals. Insufficient evidence exists on the potential impact of future …

Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise

AK Coussens, SMA Zaidi, BW Allwood… - The Lancet …, 2024 - thelancet.com
The current active–latent paradigm of tuberculosis largely neglects the documented
spectrum of disease. Inconsistency with regard to definitions, terminology, and diagnostic …

The knowns and unknowns of latent Mycobacterium tuberculosis infection

WH Boom, UE Schaible… - The Journal of clinical …, 2021 - Am Soc Clin Investig
Humans have been infected with Mycobacterium tuberculosis (Mtb) for thousands of years.
While tuberculosis (TB), one of the deadliest infectious diseases, is caused by uncontrolled …